Presentation Information
[3-P-079]Therapeutic Efficacy of Resmetirom and Semaglutide in the STAM Mouse Model From Surrogate Endpoints toward Clinical Outcome Evaluation
*Taishi Hashiguchi1 (1. SMC Laboratories)
Keywords:
MASH,fibrosis,Resmetirom,Semaglutide
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.
Comment
To browse or post comments, you must log in.Log in
